Abstract PS3-04-04: Ai predicts response to neoadjuvant therapy in breast cancer across diverse cohorts
J. Park(Yara (Norway)), K. J. Geras(Yara (Norway)), Piotr J. Wysocki(Jagiellonian University), Joanna Szpor(Jagiellonian University), Brian Piening(Providence College), Bartosz Machura(Yara (Norway)), Francisco J. Esteva(Northwell Health), Vincent Reid(Mercy Medical Center), F. M. Howard(University of Chicago), A. Przywara(Jagiellonian University), K. G. Zeng(Yara (Norway)), C. Bifulco(Providence Portland Medical Center), Joseph Cappadona(Yara (Norway)), J. Witowski(Yara (Norway))
Cited by 0
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620